Mon, 24 Jun 2019 12:00:00 EDT Clozapine Induced Weight Gain Conditions: Weight Gain; Antipsychotic Agents; Pharmacogenetics Intervention: Other: No study intervention - observational study Sponsor: Cwm Taf University Health Board (NHS) Not yet recruiting
Mon, 24 Jun 2019 12:00:00 EDT Living Green and Healthy for Teens RCT Conditions: Healthy Lifestyle; Adolescent Behavior Interventions: Behavioral: Aim2Be smartphone app system; Behavioral: BnLt smartphone app Sponsors: Population Health Research Institute; Childhood Obesity Foundation; University of British Columbia; Ayogo Health Inc.; Canadian Institutes of Health Research (CIHR) Not yet recruiting
Mon, 24 Jun 2019 12:00:00 EDT Vaccination Efficacy With Metformin in Older Adults Conditions: Aging; Age-Related Immunodeficiency; Vaccine Response Impaired Interventions: Drug: Metformin Hydrochloride Extended-Release Tablets; Biological: Influenza Vaccine Sponsor: UConn Health Recruiting
Mon, 24 Jun 2019 12:00:00 EDT Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer Conditions: Cervical Cancer; Uterine Cervical Neoplasm; Pelvic Inflammatory Disease; Radiation Toxicity; Diet Modification Interventions: Other: Omega-3 fatty acids; Other: Antioxidants; Other: Soluble fiber; Other: Probiotics; Other: Lactose restriction; Other: Fiber restriction; Other: Fat restriction Sponsor: National Institute of Cancerología Recruiting
Fri, 21 Jun 2019 12:00:00 EDT Effectiveness of a Transition Program for Adolescents With Type 1 Diabetes in the Transition to Adulthood Condition: Type 1 Diabetes Interventions: Behavioral: A Person-Centred Transition Program to Empower Adolescents With Type 1 Diabetes in the Transition to Adulthood: the STEPSTONES-DIAB Project; Other: Standard care Sponsors: Göteborg University; Karolinska University Hospital; Swedish Child Diabetes Foundation; Swedish Diabetes Foundation; Gothenburg Centre for Person-Centred Care; The Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare (FORTE) Not yet recruiting
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
FDA approves new treatment for pediatric patients with type 2 diabetes : FDA approves Victoza (liraglutide) injection for pediatric patients with type 2 diabetes. Victoza creates the same effect as GLP-1 receptor protein and is the first non-insulin drug approved since metformin in 2000.
